The company is called Ambrosia and the technique is parabiosis: https://www.inc.com/jeff-bercovici/peter-thiel-young-blood.html https://www.inc.com/jeff-bercov

The company is called Ambrosia and the technique is parabiosis: https://www.inc.com/jeff-bercovici/peter-thiel-young-blood.html https://www.inc.com/jeff-bercovici/peter-thiel-young-blood.h... They've started a clinical trial: https://clinicaltrials.gov/show/NCT02803554 https://clinicaltrials.gov/show/NCT02803554